United States Chronic Kidney Disease Drug Industry 2016 Deep Market Research Report

1 Industry Overview

1.1 Definition and Specifications of Chronic Kidney Disease Drug

1.1.1 Definition of Chronic Kidney Disease Drug

1.1.2 Specifications of Chronic Kidney Disease Drug

1.2 Classification of Chronic Kidney Disease Drug

1.3 Applications of Chronic Kidney Disease Drug

1.4 Industry Chain Structure of Chronic Kidney Disease Drug

1.5 Industry Overview of Chronic Kidney Disease Drug

1.6 Industry Policy Analysis of Chronic Kidney Disease Drug

1.7 Industry News Analysis of Chronic Kidney Disease Drug

2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drug

2.1 Bill of Materials (BOM) of Chronic Kidney Disease Drug

2.2 BOM Price Analysis of Chronic Kidney Disease Drug

2.3 Labor Cost Analysis of Chronic Kidney Disease Drug

2.4 Depreciation Cost Analysis of Chronic Kidney Disease Drug

2.5 Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drug

2.6 Manufacturing Process Analysis of Chronic Kidney Disease Drug

2.7 United States Price, Cost and Gross of Chronic Kidney Disease Drug 2011-2016

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Chronic Kidney Disease Drug Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Chronic Kidney Disease Drug Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Chronic Kidney Disease Drug Key Manufacturers in 2015

4 Production Analysis of Chronic Kidney Disease Drug by Regions, Type, and Applications

4.1 United States Production of Chronic Kidney Disease Drug by Regions 2011-2016

4.2 United States Production of Chronic Kidney Disease Drug by Type 2011-2016

4.3 United States Sales of Chronic Kidney Disease Drug by Applications 2011-2016

4.4 Price Analysis of United States Chronic Kidney Disease Drug Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Chronic Kidney Disease Drug 2011-2016

5 Consumption Volume and Consumption Value Analysis of Chronic Kidney Disease Drug by Regions

5.1 United States Consumption Volume of Chronic Kidney Disease Drug by Regions 2011-2016

5.2 United States Consumption Value of Chronic Kidney Disease Drug by Regions 2011-2016

5.3 United States Consumption Price Analysis of Chronic Kidney Disease Drug by Regions 2011-2016

6 Analysis of Chronic Kidney Disease Drug Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Chronic Kidney Disease Drug 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Chronic Kidney Disease Drug 2014-2015

6.3 Sales Overview of Chronic Kidney Disease Drug 2011-2016

6.4 Supply, Consumption and Gap of Chronic Kidney Disease Drug 2011-2016

6.5 Import, Export and Consumption of Chronic Kidney Disease Drug 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Chronic Kidney Disease Drug 2011-2016

7 Analysis of Chronic Kidney Disease Drug Industry Key Manufacturers

7.1 Actavis PLC

7.1.1 Company Profile

7.1.2 Product Picture and Specifications

7.1.2.1 Type I

7.1.2.2 Type II

7.1.2.3 Type III

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue

7.1.4 Contact Information

7.2 Amgen Inc.

7.2.1 Company Profile

7.2.2 Product Picture and Specifications

7.2.2.1 Type I

7.2.2.2 Type II

7.2.2.3 Type III

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue

7.2.4 Contact Information

7.3 Johnson & Johnson

7.3.1 Company Profile

7.3.2 Product Picture and Specifications

7.3.2.1 Type I

7.3.2.2 Type II

7.3.2.3 Type III

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue

7.3.4 Contact Information

7.4 F. Hoffmann-La Roche Ltd

7.4.1 Company Profile

7.4.2 Product Picture and Specifications

7.4.2.1 Type I

7.4.2.2 Type II

7.4.2.3 Type III

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue

7.4.4 Contact Information

7.5 Sanofi

7.5.1 Company Profile

7.5.2 Product Picture and Specifications

7.5.2.1 Type I

7.5.2.2 Type II

7.5.2.3 Type III

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue

7.5.4 Contact Information

7.6 Abbott Laboratories

7.6.1 Company Profile

7.6.2 Product Picture and Specifications

7.6.2.1 Type I

7.6.2.2 Type II

7.6.2.3 Type III

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue

7.6.4 Contact Information

7.7 Akebia Therapeutics

7.7.1 Company Profile

7.7.2 Product Picture and Specifications

7.7.2.1 Type I

7.7.2.2 Type II

7.7.2.3 Type III

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue

7.7.4 Contact Information

7.8 AMAG Pharmaceuticals

7.8.1 Company Profile

7.8.2 Product Picture and Specifications

7.8.2.1 Type I

7.8.2.2 Type II

7.8.2.3 Type III

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue

7.8.4 Contact Information

7.9 Cara Therapeutics

7.9.1 Company Profile

7.9.2 Product Picture and Specifications

7.9.2.1 Type I

7.9.2.2 Type II

7.9.2.3 Type III

7.9.3 Capacity, Production, Price, Cost, Gross and Revenue

7.9.4 Contact Information

7.10 FibroGen

7.10.1 Company Profile

7.10.2 Product Picture and Specifications

7.10.2.1 Type I

7.10.2.2 Type II

7.10.2.3 Type III

7.10.3 Capacity, Production, Price, Cost, Gross and Revenue

7.10.4 Contact Information

7.11 Keryx Biopharmaceuticals

7.11.1 Company Profile

7.11.2 Product Picture and Specifications

7.11.2.1 Type I

7.11.2.2 Type II

7.11.2.3 Type III

7.11.3 Capacity, Production, Price, Cost, Gross and Revenue

7.11.4 Contact Information

7.12 Reata Pharmaceuticals

7.12.1 Company Profile

7.12.2 Product Picture and Specifications

7.12.2.1 Type I

7.12.2.2 Type II

7.12.2.3 Type III

7.12.3 Capacity, Production, Price, Cost, Gross and Revenue

7.12.4 Contact Information

7.13 OPKO Health

7.13.1 Company Profile

7.13.2 Product Picture and Specifications

7.13.2.1 Type I

7.13.2.2 Type II

7.13.2.3 Type III

7.13.3 Capacity, Production, Price, Cost, Gross and Revenue

7.13.4 Contact Information

7.14 Pharmacosmos

7.14.1 Company Profile

7.14.2 Product Picture and Specifications

7.14.2.1 Type I

7.14.2.2 Type II

7.14.2.3 Type III

7.14.3 Capacity, Production, Price, Cost, Gross and Revenue

7.14.4 Contact Information

7.15 Raptor Pharmaceuticals

7.15.1 Company Profile

7.15.2 Product Picture and Specifications

7.15.2.1 Type I

7.15.2.2 Type II

7.15.2.3 Type III

7.15.3 Capacity, Production, Price, Cost, Gross and Revenue

7.15.4 Contact Information

7.16 Regulus Therapeutics

7.16.1 Company Profile

7.16.2 Product Picture and Specifications

7.16.2.1 Type I

7.16.2.2 Type II

7.16.2.3 Type III

7.16.3 Capacity, Production, Price, Cost, Gross and Revenue

7.16.4 Contact Information

7.17 Rockwell Medical

7.17.1 Company Profile

7.17.2 Product Picture and Specifications

7.17.2.1 Type I

7.17.2.2 Type II

7.17.2.3 Type III

7.17.3 Capacity, Production, Price, Cost, Gross and Revenue

7.17.4 Contact Information

7.18 Shield Therapeutics

7.18.1 Company Profile

7.18.2 Product Picture and Specifications

7.18.2.1 Type I

7.18.2.2 Type II

7.18.2.3 Type III

7.18.3 Capacity, Production, Price, Cost, Gross and Revenue

7.18.4 Contact Information

7.19 Takeda Pharmaceuticals

7.19.1 Company Profile

7.19.2 Product Picture and Specifications

7.19.2.1 Type I

7.19.2.2 Type II

7.19.2.3 Type III

7.19.3 Capacity, Production, Price, Cost, Gross and Revenue

7.19.4 Contact Information

7.20 Vifor Pharma Ltd

7.20.1 Company Profile

7.20.2 Product Picture and Specifications

7.20.2.1 Type I

7.20.2.2 Type II

7.20.2.3 Type III

7.20.3 Capacity, Production, Price, Cost, Gross and Revenue

7.20.4 Contact Information

7.21 Xenetic Biosciences

7.21.1 Company Profile

7.21.2 Product Picture and Specifications

7.21.2.1 Type I

7.21.2.2 Type II

7.21.2.3 Type III

7.21.3 Capacity, Production, Price, Cost, Gross and Revenue

7.21.4 Contact Information

7.22 ZS Pharma

7.22.1 Company Profile

7.22.2 Product Picture and Specifications

7.22.2.1 Type I

7.22.2.2 Type II

7.22.2.3 Type III

7.22.3 Capacity, Production, Price, Cost, Gross and Revenue

7.22.4 Contact Information

8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Chronic Kidney Disease Drug Product Types

8.5 Market Share Analysis of Different Chronic Kidney Disease Drug Price Levels

8.6 Gross Margin Analysis of Different Chronic Kidney Disease Drug Applications

9 Marketing Trader or Distributor Analysis of Chronic Kidney Disease Drug

9.1 Marketing Channels Status of Chronic Kidney Disease Drug

9.2 Traders or Distributors of Chronic Kidney Disease Drug with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Chronic Kidney Disease Drug

9.4 United States Import, Export and Trade Analysis of Chronic Kidney Disease Drug

10 Development Trend of Chronic Kidney Disease Drug Industry 2016-2021

10.1 Capacity and Production Overview of Chronic Kidney Disease Drug 2016-2021

10.2 Production Market Share by Product Types of Chronic Kidney Disease Drug 2016-2021

10.3 Sales and Sales Revenue Overview of Chronic Kidney Disease Drug 2016-2021

10.4 United States Sales of Chronic Kidney Disease Drug by Applications 2016-2021

10.5 Import, Export and Consumption of Chronic Kidney Disease Drug 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Chronic Kidney Disease Drug 2016-2021

11 Industry Chain Suppliers of Chronic Kidney Disease Drug with Contact Information

11.1 Major Raw Materials Suppliers of Chronic Kidney Disease Drug with Contact Information

11.2 Manufacturing Equipment Suppliers of Chronic Kidney Disease Drug with Contact Information

11.3 Major Players of Chronic Kidney Disease Drug with Contact Information

11.4 Key Consumers of Chronic Kidney Disease Drug with Contact Information

11.5 Supply Chain Relationship Analysis of Chronic Kidney Disease Drug

12 New Project Investment Feasibility Analysis of Chronic Kidney Disease Drug

12.1 New Project SWOT Analysis of Chronic Kidney Disease Drug

12.2 New Project Investment Feasibility Analysis of Chronic Kidney Disease Drug

13 Conclusion of the United States Chronic Kidney Disease Drug Industry 2016 Market Research Report

Figure Picture of Chronic Kidney Disease Drug

Table Product Specifications of Chronic Kidney Disease Drug

Table Classification of Chronic Kidney Disease Drug

Figure United States Sales Market Share of Chronic Kidney Disease Drug by Product Types in 2015

Table Applications of Chronic Kidney Disease Drug

Figure United States Sales Market Share of Chronic Kidney Disease Drug by Applications in 2015

Figure Industry Chain Structure of Chronic Kidney Disease Drug

Table United States Industry Overview of Chronic Kidney Disease Drug

Table Industry Policy of Chronic Kidney Disease Drug

Table Industry News List of Chronic Kidney Disease Drug

Table Bill of Materials (BOM) of Chronic Kidney Disease Drug

Table Bill of Materials (BOM) Price of Chronic Kidney Disease Drug

Table Labor Cost of Chronic Kidney Disease Drug

Table Depreciation Cost of Chronic Kidney Disease Drug

Table Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drug in 2015

Figure Manufacturing Process Analysis of Chronic Kidney Disease Drug

Table United States Price Analysis of Chronic Kidney Disease Drug 2011-2016 (USD/Unit)

Table United States Cost Analysis of Chronic Kidney Disease Drug 2011-2016 (USD/Unit)

Table United States Gross Analysis of Chronic Kidney Disease Drug 2011-2016

Table Capacity (Unit) and Commercial Production Date of United States Chronic Kidney Disease Drug Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Chronic Kidney Disease Drug Manufacturers in 2015

Table R&D Status and Technology Source of United States Chronic Kidney Disease Drug Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Chronic Kidney Disease Drug Key Manufacturers in 2015

Table United States Production of Chronic Kidney Disease Drug by Regions 2011-2016 (Unit)

Table United States Production Market Share of Chronic Kidney Disease Drug by Regions 2011-2016

Figure United States Production Market Share of Chronic Kidney Disease Drug by Regions in 2014

Figure United States Production Market Share of Chronic Kidney Disease Drug by Regions in 2015

Table United States Production of Chronic Kidney Disease Drug by Types in 2011-2016 (Unit)

Table United States Production Market Share of Chronic Kidney Disease Drug by Type in 2011-2016

Figure United States Production Market Share of Chronic Kidney Disease Drug by Type in 2014

Figure United States Production Market Share of Chronic Kidney Disease Drug by Type in 2015

Table United States Sales of Chronic Kidney Disease Drug by Applications 2011-2016 (Unit)

Table United States Production Market Share of Chronic Kidney Disease Drug by Applications 2011-2016

Figure United States Production Market Share of Chronic Kidney Disease Drug by Applications in 2014

Figure United States Production Market Share of Chronic Kidney Disease Drug by Applications in 2015

Table Price Comparison of United States Chronic Kidney Disease Drug Key Manufacturers in 2015 (USD/Unit)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Chronic Kidney Disease Drug 2011-2016

Table United States Consumption Volume of Chronic Kidney Disease Drug by Regions 2011-2016 (Unit)

Table United States Consumption Volume Market Share of Chronic Kidney Disease Drug by Regions 2011-2016

Figure United States Consumption Volume Market Share of Chronic Kidney Disease Drug by Regions in 2014

Figure United States Consumption Volume Market Share of Chronic Kidney Disease Drug by Regions in 2015

Table United States Consumption Value of Chronic Kidney Disease Drug by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Chronic Kidney Disease Drug by Regions 2011-2016

Figure United States Consumption Value Market Share of Chronic Kidney Disease Drug by Regions in 2014

Figure United States Consumption Value Market Share of Chronic Kidney Disease Drug by Regions in 2015

Table Consumption Price of Chronic Kidney Disease Drug by Regions 2011-2016 (USD/Unit)

Table United States and Major Manufacturers Capacity of Chronic Kidney Disease Drug 2011-2016 (Unit)

Table United States Capacity Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Chronic Kidney Disease Drug 2011-2016 (Unit)

Table United States Production Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Chronic Kidney Disease Drug 2011-2016 (Unit)

Table United States Sales Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Chronic Kidney Disease Drug 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Chronic Kidney Disease Drug Manufacturers 2011-2016

Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Chronic Kidney Disease Drug 2011-2016

Figure United States Capacity Utilization Rate of Chronic Kidney Disease Drug 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Chronic Kidney Disease Drug 2011-2016

Figure United States Production Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2014

Figure United States Production Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2015

Figure United States Sales Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2014

Figure United States Sales Market Share of Major Chronic Kidney Disease Drug Manufacturers in 2015

Figure United States Sales (Unit) and Growth Rate of Chronic Kidney Disease Drug 2011-2016

Table United States Supply, Consumption and Gap of Chronic Kidney Disease Drug 2011-2016 (Unit)

Table United States Import, Export and Consumption of Chronic Kidney Disease Drug 2011-2016 (Unit)

Table Price of United States Chronic Kidney Disease Drug Major Manufacturers 2011-2016 (USD/Unit)

Table Gross Margin of United States Chronic Kidney Disease Drug Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Chronic Kidney Disease Drug 2011-2016 (M USD)

Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Chronic Kidney Disease Drug 2011-2016

Table Actavis PLC Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Actavis PLC

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Actavis PLC 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Actavis PLC 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Actavis PLC 2011-2016

Table Actavis PLC Chronic Kidney Disease Drug SWOT Analysis

Table Amgen Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Amgen Inc.

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen Inc. 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Amgen Inc. 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Amgen Inc. 2011-2016

Table Amgen Inc. Chronic Kidney Disease Drug SWOT Analysis

Table Johnson & Johnson Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Johnson & Johnson

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Johnson & Johnson 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Johnson & Johnson 2011-2016

Table Johnson & Johnson Chronic Kidney Disease Drug SWOT Analysis

Table F. Hoffmann-La Roche Ltd Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of F. Hoffmann-La Roche Ltd

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche Ltd 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of F. Hoffmann-La Roche Ltd 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of F. Hoffmann-La Roche Ltd 2011-2016

Table F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drug SWOT Analysis

Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Sanofi

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Sanofi 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Sanofi 2011-2016

Table Sanofi Chronic Kidney Disease Drug SWOT Analysis

Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Abbott Laboratories

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Abbott Laboratories 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Abbott Laboratories 2011-2016

Table Abbott Laboratories Chronic Kidney Disease Drug SWOT Analysis

Table Akebia Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Akebia Therapeutics

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Akebia Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Akebia Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Akebia Therapeutics 2011-2016

Table Akebia Therapeutics Chronic Kidney Disease Drug SWOT Analysis

Table AMAG Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of AMAG Pharmaceuticals

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AMAG Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of AMAG Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of AMAG Pharmaceuticals 2011-2016

Table AMAG Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis

Table Cara Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Cara Therapeutics

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cara Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Cara Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Cara Therapeutics 2011-2016

Table Cara Therapeutics Chronic Kidney Disease Drug SWOT Analysis

Table FibroGen Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of FibroGen

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of FibroGen 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of FibroGen 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of FibroGen 2011-2016

Table FibroGen Chronic Kidney Disease Drug SWOT Analysis

Table Keryx Biopharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Keryx Biopharmaceuticals

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Keryx Biopharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Keryx Biopharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Keryx Biopharmaceuticals 2011-2016

Table Keryx Biopharmaceuticals Chronic Kidney Disease Drug SWOT Analysis

Table Reata Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Reata Pharmaceuticals

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Reata Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Reata Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Reata Pharmaceuticals 2011-2016

Table Reata Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis

Table OPKO Health Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of OPKO Health

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of OPKO Health 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of OPKO Health 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of OPKO Health 2011-2016

Table OPKO Health Chronic Kidney Disease Drug SWOT Analysis

Table Pharmacosmos Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Pharmacosmos

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pharmacosmos 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Pharmacosmos 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Pharmacosmos 2011-2016

Table Pharmacosmos Chronic Kidney Disease Drug SWOT Analysis

Table Raptor Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Raptor Pharmaceuticals

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Raptor Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Raptor Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Raptor Pharmaceuticals 2011-2016

Table Raptor Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis

Table Regulus Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Regulus Therapeutics

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Regulus Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Regulus Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Regulus Therapeutics 2011-2016

Table Regulus Therapeutics Chronic Kidney Disease Drug SWOT Analysis

Table Rockwell Medical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Rockwell Medical

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Rockwell Medical 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Rockwell Medical 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Rockwell Medical 2011-2016

Table Rockwell Medical Chronic Kidney Disease Drug SWOT Analysis

Table Shield Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Shield Therapeutics

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shield Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Shield Therapeutics 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Shield Therapeutics 2011-2016

Table Shield Therapeutics Chronic Kidney Disease Drug SWOT Analysis

Table Takeda Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Takeda Pharmaceuticals

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Takeda Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Takeda Pharmaceuticals 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Takeda Pharmaceuticals 2011-2016

Table Takeda Pharmaceuticals Chronic Kidney Disease Drug SWOT Analysis

Table Vifor Pharma Ltd Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Vifor Pharma Ltd

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Vifor Pharma Ltd 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Vifor Pharma Ltd 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Vifor Pharma Ltd 2011-2016

Table Vifor Pharma Ltd Chronic Kidney Disease Drug SWOT Analysis

Table Xenetic Biosciences Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of Xenetic Biosciences

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Xenetic Biosciences 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of Xenetic Biosciences 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of Xenetic Biosciences 2011-2016

Table Xenetic Biosciences Chronic Kidney Disease Drug SWOT Analysis

Table ZS Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Chronic Kidney Disease Drug Picture and Specifications of ZS Pharma

Table Chronic Kidney Disease Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ZS Pharma 2011-2016

Figure Chronic Kidney Disease Drug Capacity (Unit), Production (Unit) and Growth Rate of ZS Pharma 2011-2016

Figure Chronic Kidney Disease Drug Production (Unit) and United States Market Share of ZS Pharma 2011-2016

Table ZS Pharma Chronic Kidney Disease Drug SWOT Analysis

Table Chronic Kidney Disease Drug Price by Regions 2011-2016

Table Chronic Kidney Disease Drug Price by Product Types 2011-2016

Table Chronic Kidney Disease Drug Price by Companies 2011-2016

Table Chronic Kidney Disease Drug Gross Margin by Companies 2011-2016

Table Price Comparison of Chronic Kidney Disease Drug by Regions 2011-2016 (USD/Unit)

Table Price of Different Chronic Kidney Disease Drug Product Types (USD/Unit)

Table Market Share of Different Chronic Kidney Disease Drug Price Level

Table Gross Margin of Different Chronic Kidney Disease Drug Applications

Table Marketing Channels Status of Chronic Kidney Disease Drug

Table Traders or Distributors of Chronic Kidney Disease Drug with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Chronic Kidney Disease Drug (USD/Unit) in 2015

Table United States Import, Export, and Trade of Chronic Kidney Disease Drug (Unit)

Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Chronic Kidney Disease Drug 2016-2021

Figure United States Capacity Utilization Rate of Chronic Kidney Disease Drug 2016-2021

Table United States Chronic Kidney Disease Drug Production by Type 2016-2021 (Unit)

Table United States Chronic Kidney Disease Drug Production Market Share by Type 2016-2021

Figure United States Production Market Share of Chronic Kidney Disease Drug by Type in 2021

Figure United States Sales (Unit) and Growth Rate of Chronic Kidney Disease Drug 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Chronic Kidney Disease Drug 2016-2021

Figure United States Sales of Chronic Kidney Disease Drug by Applications 2016-2021 (Unit)

Table United States Production Market Share of Chronic Kidney Disease Drug by Applications 2016-2021

Figure United States Production Market Share of Chronic Kidney Disease Drug by Applications in 2021

Table United States Production, Import, Export and Consumption of Chronic Kidney Disease Drug 2016-2021 (Unit)

Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Chronic Kidney Disease Drug 2016-2021

Table Major Raw Materials Suppliers of Chronic Kidney Disease Drug with Contact Information

Table Manufacturing Equipment Suppliers of Chronic Kidney Disease Drug with Contact Information

Table Major Players of Chronic Kidney Disease Drug with Contact Information

Table Key Consumers of Chronic Kidney Disease Drug with Contact Information

Table Supply Chain Relationship Analysis of Chronic Kidney Disease Drug

Table New Project SWOT Analysis of Chronic Kidney Disease Drug

Table New Project Investment Feasibility Analysis of Chronic Kidney Disease Drug

Table Part of Interviewees Record List